FONR — Fonar Corporation
NASDAQ · Healthcare · Diagnostics & Research
Fonar Corporation (FONR) is a diagnostics & research company listed on NASDAQ. It is led by Timothy R. Damadian M.D., based in 110 Marcus Drive, Melville, NY, United States, 11747, with about 535 employees. FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with legal and regulatory matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.
Latest reported FONR revenue for 2025-09-30 was $26.0M. Net income was $2.7M. Revenue was down 75.0% from 2025-06-30 to 2025-09-30. FONR currently screens at market cap $120.2M and trailing P/E 19.1.
Use this FONR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FONR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FONR SEC filings page. Lician reads the product cache first so this HTML stays unique to Fonar Corporation even when a live quote feed is slow.
About Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with legal and regulatory matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.
FONR Key Statistics
Market Cap
$120.20M
P/E Ratio
19.09
EPS
$0.00
Revenue
$104.35M
Net Income
$8.33M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+1.4%
Profit Margin
8.0%
Employees
535
FONR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $104.35M | $102.88M | $98.65M | $97.59M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $8.33M | $10.57M | $12.13M | $17.23M |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
Total Assets
$216.91M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$56.33M
Operating Cash Flow
$11.26M
Free Cash Flow
$0.00
Fonar Corporation Company Information
- Chairman, President, CEO & Treasurer
- Timothy R. Damadian M.D.
- Headquarters
- 110 Marcus Drive, Melville, NY, United States, 11747
- Website
- www.fonar.com
- Phone
- 631 694 2929
- IPO / Founded
- 1987-01-01
- Sector
- Healthcare
- Industry
- Diagnostics & Research